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Broad-Range PCR in Selected Episodes
of Prosthetic Joint Infection
The use of eubacterial PCR of the 16S rRNA (PCR) for
diagnosing prosthetic-joint-associated infections (PJIs) is
still a matter of debate. Several drawbacks need to be
considered when using this technique, including the lack
of susceptibility results (except for methicillin-resistant
Staphylococcus aureus) and problems in identifying a
mixture of bacterial species in a single specimen [1]. A
number of studies have indicated that the routine use of
PCR in PJIs does not offer a diagnostic advantage over
bacterial culture [2–4]. However, this molecular method
can detect bacterial DNA in samples when conventional
cultures are negative due to previous antimicrobial
exposure or unfavorable growth conditions. Taking these
considerations into account, we use PCR only if the
chance of bacterial growth is low because of previous
surgical and antimicrobial treatment or previous negative
culture results. In order to (re)assess the diagnostic value
of PCR in those selected episodes of suspected PJI in
which this method had been applied, we performed a
retrospective study to define patient characteristics and to
estimate the specificity and sensitivity of PCR versus
bacterial culture. Our orthopedic surgery clinic is a 48-bed
unit that acts as a primary care center for all types of
orthopedic surgery of the extremities and as a tertiary care
center for patients needing revision arthroplasty.
The study population consisted of patients with a joint
prosthesis who were seen at our clinic from 2001 through
2005, and from whom specimens for bacterial culture and
PCR were obtained because of possible PJI. The suspicion
of PJI was based on clinical signs such as joint pain,
effusion, erythema and warmth at the implant site, and/or
implant loosening. Patient history prior to the diagnostic
intervention was assessed for (1) antimicrobial treatment,
(2) number of revisions performed on the affected joint,
(3) confirmed and treated infection involving the affected
joint within the last 24 months, and (4) implant loosening
£ 12 months after implantation without other clinical
signs of infection. Specimens (synovial fluid and/or biop-
sies from periprosthetic tissue) were obtained either dur-
ing aspiration prior to surgery or during arthroscopy or
open surgery. Bacterial culture and histopathologic diag-
nostics were performed as described previously [5]. The
decision whether or not to use PCR was made by the
physicians in charge following a review of the patient’s
history and prior to the intervention. However, the phy-
sicians were not involved in either analyzing or inter-
preting the data. Specimens were sent to a reference
laboratory for analysis [6]. The technique is based on the
amplification of bacterial 16S ribosomal DNA [6]. Criteria
for definite PJI included the presence of a sinus tract
communicating with the prosthesis or purulence sur-
rounding the prosthesis at the time of surgery or acute or
chronic inflammation consistent with infection on histo-
pathologic examination [1, 7]. Infection was excluded
when the above-mentioned criteria were not fulfilled, no
antimicrobial treatment was administered after the epi-
sode, and no relapse occurred for at least 1 year.
Specimens for both PCR and bacterial culture were
obtained in 29 episodes of possible PJI among 26 patients.
This number accounted for 7.6% (23 episodes) of all
revision arthroplasties (n = 301) and 6.8% (6 episodes)
of all joint punctures (n = 88) during the study period.
Patient characteristics are presented in table 1. Most
episodes (48%) included a history of three or more sur-
gical interventions (median 4, IQR 3–5) on the affected
joint within a median time of 3.25 years (IQR 0.9–10.5)
prior to the diagnostic intervention. The median number
of obtained specimens per patient for bacterial culture
was five (IQR 3–7) and for PCR, one (IQR 1–2).
No infection was present in 17 (59%) of the 29 episodes,
although the duration of follow-up was £ 12 months in
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two cases (4, 11 months) due to non-episode-related
death and loss to follow-up, respectively. The PCR was
negative in all 17 cases with clinically excluded infection.
In contrast, there was bacterial growth in five episodes,
but these were interpreted as contamination. In the
infection episodes, one inaccurate PCR result was con-
sidered to be a false-positive. Based on these findings,
the specificity for bacterial culture was 71% and for
PCR 94%.
The criteria for PJI were fulfilled in 12 (41%) of the
29 episodes; this accounted for 8.5% of 142 confirmed
PJI episodes (including 62% referred cases) during the
study period. The results of bacterial culture and PCR
are presented in table 2. In five episodes, both diagnostic
approaches identified the same microorganism. However,
in two of these, PCR revealed only one pathogen, while
two distinct microorganisms grew in culture. In two
further episodes, the pathogen was identified either
only by bacterial culture or only by PCR. Hence, the
sensitivity for bacterial culture was 58% and for PCR,
50%.
Little information is available for assisting clinical
practitioners in selecting episodes in which PCR may be
superior or complementary to bacterial culture for diag-
nosing PJI. The previous history of the patients included
in this study (Table 1) highlights the importance of dis-
tinguishing PJI from other causes of joint failure. Based
on this history, we decided it was reasonable to expand
diagnostic means by an additional tool in these selected
episodes.
Broad-range PCR and more advanced molecular
methods show a high specificity (96%–100%) [3, 4, 8–12],
but often a poor sensitivity (£ 50%) in diagnosing PJI
[3, 4, 8, 10, 12]. Similarly, the specificity was excellent in
Table 1
Demographic data and history of 26 patients with 29 episodes
of suspected prosthetic-joint-associated infections (PJIs) from











Patient history prior to presentation
‡ 3 revisions performed at the
affected joint
14 (48%)
Confirmed and treated infection at the
affected joint within £ 24 months
9 (31%)
Previous antimicrobial treatment 8 (27.5%)
0–2 Weeks prior to intervention 3
2–4 Weeks prior to intervention 1
4–8 weeks prior to intervention 4
Implant loosening £ 12 months after




Results of bacterial culture and broad-range PCR in 12 episodes of confirmed PJI.








1 Synovial fluid 2/2 Streptococcus pyogenes 1/1 Streptococcus pyogenes
2a Periprosthetic tissue 2/13 Propionibacterium sp. 1/8 Streptococcus infantis
3 Synovial fluid 1/1 Staphylococcus aureus 1 Negative
4 Periprosthetic tissue 1 No growth 1 Negative
5 Periprosthetic tissue 1 No growth 1 Negative
6 Synovial fluid 1 No growth 1/1 Streptococcus bovis
7 Periprosthetic tissue 5/11 Staphylococcus aureus 1/1 Staphylococcus aureus
1/11 Enterococcus faecalis
8 Periprosthetic tissue 6 No growth 2 Negative
9 Periprosthetic tissue 6/9 Staphylococcus epidermidis 1/1 Staphylococcus epidermidis
10 Periprosthetic tissue 5/6 Pseudomonas aeruginosa 2/2 Pseudomonas aeruginosa
1/6 Enterococcus faecalis
11 Periprosthetic tissue 1/5b Staphylococcus epidermidis 1/1 Staphylococcus epidermidis
12 Periprosthetic tissue 5 No growth 1 Negative
a Identification of the pathogen in this episode was inconclusive, since in both diagnostic methods the ratio of number of positive: total
number of specimens was low. However, based on the previous history (duration of symptoms 19 months) and the small fragment for
amplification isolated from the biopsy, Propionibacterium sp. was interpreted as possible pathogen, and Streptococcus infantis as contami-
nation; b Results from diagnostic arthroscopy. Four weeks later, one-stage exchange was performed and Staphylococcus epidermidis grew in 8 of
16 obtained biopsies
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our selected episodes. In all episodes with a previous
history of multiple revisions or previously treated PJI,
PCR remained negative when no infection was present.
Also, in only one out of six episodes with early implant
loosening (£ 12 months after implantation) but no other
clinical signs of PJI was an infection present, and the PCR
results matched accordingly. Importantly, in five episodes,
PCR was useful in identifying false-positive results from
bacterial culture.
The sensitivity of the PCR, however, was poor (50%).
The overall sensitivity in diagnosing PJI increased to 67%
when both PCR and bacterial culture were considered
together (i.e. one or other or both positive). Since our
study was performed retrospectively, and patients selected
for PCR were not recruited according to strictly prede-
fined criteria, the study could have been influenced by a
selection bias. Therefore, no immediate recommendation
about the use of PCR in PJI can be made.
However, the expense and diagnostic value of PCR in
comparison to bacterial culture [2–4] warrant the use of
this molecular method only selectively and not routinely,
and in addition to bacterial culture. In our center, PCR has
been performed in fewer than 10% of all revision arthro-
plasties (i.e. in patients with a complex history of joint
disease) and found to have only a limited diagnostic value.
In fewer than 20% of the episodes, PCR was helpful in
recognizing false-positive culture results. In terms of the
applicability of PCR in clinical practice, more studies are
required to identify both a patient population and a diag-
nostic strategy in which the use of such a molecular tool is
beneficial in diagnosing or excluding PJIs.
F.H.R. De Man, P. Graber, M. Lu¨em, W. Zimmerli,
P.E. Ochsner, P. Sendi
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